Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to explore the effect of one week inpatient self-management program (SMP) in patients with fibromyalgia. The SMP is delivered as group education/activities by allied health professionals.
This study will determine if one week inpatient SMP can reduce FM symptoms and increase patients self-efficacy, health status, quality of life and being active health consumers.
The one-week SMP is designed to help people manage their rheumatic disease and challenges in daily life. The program has the same core concepts as outpatient programmes and comprises information, discussions on how to cope with the disease and daily life, cognitive management skills, exercise, engagement in self-care and interactions with healthcare professionals. During the program, the inpatient education unit takes up to 16 patients and 5 relatives per week within one diagnostic group. Each educational session lasts for 1.5-2.5 hours and the physical activity sessions for 0.5-1 hour. In the evening group sessions, the patients are divided into small groups of approximately five participants. They talk together for one hour under leadership of one health professional who is educated in coaching. The focus is on coping with the disease and daily life.
For the intervention group there will be a one year follow up study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Waiting list | No Intervention | ||
| Self-management program | Experimental | One week self-management program |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Self-management program | Behavioral | Participants will receive a one week inpatient self-management program |
|
| Measure | Description | Time Frame |
|---|---|---|
| EC-17 (Effective Musculoskeletal Consumer Scale) | Baseline, 3 weeks before the program, 3 weeks and 6 months after the program | |
| GHQ20 (General Health Questionnaire) | Baseline, 3 weeks before the program, 3 weeks and 6 months after the program |
| Measure | Description | Time Frame |
|---|---|---|
| FIQ (Fibromyalgia Impact Questionnaire) | Baseline, 3 weeks before the program, 3 weeks and 6 months after the program | |
| SF-36 (Short Form Health Survey) | Baseline, 3 weeks before the program, 3 weeks and 6 months after the program |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Knut Mikkelsen, MD | Revmatismesykehuset AS, Lillehammer, Norway | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lillehammer Hospital for Rheumatic Diseases | Lillehammer | Oppland | 2609 | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23013162 | Derived | Hamnes B, Mowinckel P, Kjeken I, Hagen KB. Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: a randomised controlled trial. BMC Musculoskelet Disord. 2012 Sep 26;13:189. doi: 10.1186/1471-2474-13-189. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005356 | Fibromyalgia |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000073278 | Self-Management |
| D010353 | Patient Education as Topic |
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D006266 | Health Education |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Self-efficacy Scale | Baseline, 3 weeks before the program, 3 weeks and 6 months after the program |
| D009422 |
| Nervous System Diseases |
| D011314 | Preventive Health Services |